Your browser doesn't support javascript.
loading
Safety and efficacy of idursulfase in the treatment of mucopolysaccharidosis II (Hunter syndrome): a post-marketing study in Japan.
Ueda, Kazuo; Hokugo, Jiro.
Affiliation
  • Ueda K; Rare Disease Medical, Sanofi Genzyme Medical, Sanofi K.K ., Tokyo, Japan.
  • Hokugo J; Post-Authorization Regulatory Studies, Medical Affairs, Sanofi K.K ., Tokyo, Japan.
Expert Opin Drug Saf ; 19(7): 891-901, 2020 Jul.
Article in En | MEDLINE | ID: mdl-32342708
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uronic Acids / Mucopolysaccharidosis II / Enzyme Replacement Therapy / Iduronate Sulfatase Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Japón
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uronic Acids / Mucopolysaccharidosis II / Enzyme Replacement Therapy / Iduronate Sulfatase Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Expert Opin Drug Saf Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Japón